Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 8, 2002, Pages 914-921

  Kong, Gu ^a   Kim, Eun Kyung ^b   Kim, Wan Sup ^b   Lee, Kyu Taek ^c,d   Lee, Yong Wook ^c   Lee, Jong Kyun ^c   Paik, Seung Woon ^c   Rhee, Jong Chul ^c  

^a Hanyang University   (South Korea)

^b Eulji University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

Angiogenesis; Apoptosis; Cyclooxygenase 2; Inducible nitric oxide synthase; Pancreatic cancer; Proliferation; Survival

Indexed keywords

ANTIBODY; BILIRUBIN; CA 19-9 ANTIGEN; CD34 ANTIGEN; CYCLOOXYGENASE 2; ISOENZYME; KI 67 ANTIGEN; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANGIOGENESIS; ANTIBODY LABELING; APOPTOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER GROWTH; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; NICK END LABELING; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0036381118     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02829.x     Document Type: Article

References (45)

1. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349: 485-9.
2. Pancreas Club. Pancreas Club Meeting May 11, 1997 Bethesda Maryland. Am. J. Surg. 1998; 175: 172-8.
3. Wu KK. Inducible cyclooxygenase and nitric oxide synthase. Adv. Pharmacol. 1995; 33: 179-207.
4. Vane JR, Mitchell JA, Appleton I et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl Acad. Sci. USA 1994; 91: 2046-50.
5. Salvemini D, Misko TP, Masferrer JL et al. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl Acad. Sci. USA 1993; 90: 7240-4.
6. Salvemini D, Settle SL, Masferrer JL et al. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br. J. Pharmacol. 1995; 114: 1171-8.
7. Brune B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. 1998; 351: 261-72.
8. Cifone MG, Cironi L, Meccia MA et al. Role of nitric oxide in cell-mediated tumor cytotoxicity. Adv. Neuroimmunol. 1995; 5: 443-61.
9. Cui S, Reichner JS, Mateo RB et al. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 1994; 54: 2462-7.
10. Jenkins DC, Charles IG, Thomsen LL et al. Roles of nitric oxide in tumor growth. Proc. Natl Acad. Sci. USA 1995; 92: 4392-6.
11. Williams CS, Tsujii M, Reese J et al. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 2000; 105: 1589-94.
12. Oshima M, Dinchuk JE, Kargman SL et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-9.
13. Sheng H, Shao J, Kirkland SC et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 1997; 99: 2254-9.
14. Tucker ON, Dannenberg AJ, Yang EK et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 1999; 59: 987-90.
15. Koshiba T, Hosotani R, Miyamoto Y et al. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int. J. Pancreatol. 1999; 26: 69-76.
16. Molina MA, Sitja-Arnau M, Lemoine MG et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 1999; 59: 4356-62.
17. Ding XZ, Tong WG, Adrian TE. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res. 2000; 20: 2625-31.
18. Hajri A, Metzger E, Vallat F et al. Role of nitric oxide in pancreatic tumor growth: in vivo and in vitro studies. Br. J. Cancer 1998; 78: 841-9.
19. Gansauge S, Nussler AK, Beger HG et al. Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ. 1998; 9: 611-17.
20. Wilson KT, Fu S, Ramanujam KS et al. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998; 58: 2929-34.
21. Mei JM, Hord NG, Winterstein DF et al. Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells. FASEB J. 2000; 14: 1188-201.
22. Cahlin C, Gelin J, Delbro D et al. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res. 2000; 60: 1742-9.
23. Swierkosz TA, Mitchell JA, Warner TD et al. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol. 1995; 114: 1335-42.
24. Bishop-Bailey D, Larkin SW, Warner TD et al. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br. J. Pharmacol. 1997; 121: 125-33.
25. Lowenstein CJ, Glatt CS, Bredt DS et al. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl Acad. Sci. USA 1992; 89: 6711-15.
26. Arias-Negrete S, Keller K, Chadee K. Proinflammatory cytokines regulate cyclo-oxygenase-2 mRNA expression in human macrophages. Biochem. Biophys. Res. Commun. 1995; 208: 582-9.
27. Diaz-Cazorla M, Perez-Sala D, Lamas S. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J. Am. Soc. Nephrol. 1999; 10: 943-52.
28. Perkins DJ, Kniss DA. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J. Leukoc. Biol. 1999; 65: 792-9.
29. Salvemini D, Masferrer JL. Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies. Methods Enzymol. 1996; 269: 12-25.
30. Tetsuka T, Daphna-Iken D, Miller BW et al. Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 1996; 97: 2051-6.
31. DelaTorre A, Schroeder RA, Kuo PC. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem. Biophys. Res. Commun. 1997; 238: 703-6.
32. Perkins DJ, Kniss DA. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J. Leukoc. Biol. 1999; 65: 792-9.
33. Brune B, Golkel C, von Knethen A. Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 1996; 229: 396-401.
34. von Knethen A, Brune B. Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J. 1997;11: 887-95.
35. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274: 782-4.
36. Van Antwerp DJ, Martin SJ, Kafri T et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996; 274: 787-9.
37. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 1994; 302: 723-7.
38. Lander HM, Ogiste JS, Pearce SF et al. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 1995; 270: 7017-20.
39. Tsujii M, Kawano S, Tsuji S et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-16.
40. Ambs S, Merriam WG, Bennett WP et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998; 58: 334-41.
41. Fujita T, Matsui M, Takaku K et al. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res. 1998; 58: 4823-6.
42. Tsujii M, Kawano S, DuBois RN. Free in PMC, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA 1997; 94: 3336-40.
43. Yagihashi N, Kasajima H, Sugai S et al. Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch. 2000; 436: 109-14.
44. Achiwa H, Yatabe Y, Hida T et al. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res. 1999; 5: 1001-5.
45. Lundin J, Nordling S, von Boguslawsky K et al. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res. 1995; 15: 2659-68.